1. Home
  2. Stock quotes
  3. Kaleido Biosciences
  4. Financial Statements
  5. Balance Sheet
Kaleido Biosciences logo
Kaleido Biosciences KLDO
$ 0.29 -3.69%
mail-toReport an Error

Annual report 2021
added 12-23-2023

report update icon

Kaleido Biosciences Balance Sheet 2011-2024 | KLDO

Annual Balance Sheet Kaleido Biosciences

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Net Debt

 - -25.2 M -50.8 M -63.4 M -13.5 M 2.22 M - - - - -

Long Term Debt

 5.55 M 18.4 M 20.4 M 14.8 M 14.8 M 4.95 M - - - - -

Long Term Debt Current

 - 2.63 M - - - - - - - - -

Total Non Current Liabilities

 - 22.2 M 23 M 15.8 M 70.6 M 20.7 M - - - - -

Total Current Liabilities

 29.7 M 16.7 M 10.4 M 11.3 M - - - - - - -

Total Liabilities

 39.5 M 38.8 M 33.4 M 28.3 M 74.4 M 21.9 M - - - - -

Deferred Revenue

 - 498 K - - - - - - - - -

Retained Earnings

 -364 M -274 M -193 M -106 M -44.5 M -16.9 M - - - - -

Total Assets

 50.1 M 59.3 M 82.3 M 85.3 M 30.7 M 4.99 M - - - - -

Cash and Cash Equivalents

 - 46.2 M 71.2 M 78.3 M - - - - - - -

Book Value

 10.6 M 20.5 M 48.9 M 57 M -43.7 M -16.9 M - - - - -

Total Shareholders Equity

 10.6 M 20.5 M 48.9 M -96.2 M - - - - - - -

All numbers in USD currency

Quarterly Balance Sheet Kaleido Biosciences

2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Long Term Debt

 - - - - 5.55 M 15.1 M 17.7 M 16.4 M 18.4 M 19.6 M 20.7 M 20.6 M 20.4 M 20.4 M 20.4 M 20.4 M 14.8 M 14.8 M 14.8 M 14.8 M - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Non Current Liabilities

 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Liabilities

 - - - - 39.5 M 38.6 M 34 M 33.3 M 38.8 M 37.2 M 35.7 M 33.2 M 33.4 M 33.4 M 33.4 M 33.4 M 28.3 M 28.3 M 28.3 M 28.3 M - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Deferred Revenue

 - - - - 828 K 150 K 189 K 281 K 498 K 498 K 498 K 498 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Retained Earnings

 - - - - -364 M -344 M -321 M -297 M -274 M -254 M -231 M -212 M -193 M -193 M -193 M -193 M -106 M -106 M -106 M -106 M - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Assets

 - - - - 50.1 M 67.8 M 84.3 M 105 M 59.3 M 73.1 M 87 M 66.8 M 82.3 M 82.3 M 82.3 M 82.3 M 85.3 M 85.3 M 85.3 M 85.3 M - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Cash and Cash Equivalents

 - - - - 38.5 M 55.7 M 72 M 92.4 M 46.2 M 46.2 M 46.2 M 46.2 M 71.2 M 71.2 M 71.2 M 71.2 M 76.1 M 76.1 M 76.1 M 76.1 M 28.7 M - - - - - - - - - - - - - - - - - - - - - - - - - - -

Book Value

 - - - - 10.6 M 29.2 M 50.3 M 71.8 M 20.5 M 35.9 M 51.3 M 33.6 M 48.9 M 48.9 M 48.9 M 48.9 M 57 M 57 M 57 M 57 M - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Shareholders Equity

 - - - - 10.6 M 29.2 M 50.3 M 71.8 M 20.5 M 35.9 M 51.3 M 33.6 M 48.9 M 66 M 48.9 M 48.9 M -96.2 M -96.2 M -96.2 M -96.2 M -43.7 M - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency